278 completed, 42 terminated, 10 unknown, 8 withdrawn. 130 Phase 3, 108 Phase 4, 59 Phase 2, 23 Phase 1, 21 Not applicable.
Follow Forest Laboratories: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDD Levomilnacipran, Quetiapine - Major Depressive Disorder | Phase 3 | Completed | Duke University | 60 | 2017-01-23 | 2019-08-14 |
| Antibiotic Prophylaxis in Open Fractures Ceftaroline - Open Fractures | Phase 4 | Unknown | Olayemi Osiyemi MD | 50 | 2016-12-01 | 2016-10-28 |
| Preventing Infections in Orthopaedic Patients Open Fracture | Unknown | Olayemi Osiyemi MD | 50 | 2016-11-01 | 2016-10-28 | |
| Ceftaroline Diffusion Into Cerebrospinal Fluid of Children Ceftaroline - Cerebrospinal Fluid Shunts, Ventriculoperitoneal Shunt | Phase 1 | Unknown | Basim Asmar | 12 | 2016-08-01 | 2018-10-04 |
| Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health Outcome Alzheimer Disease | Completed | NYU Langone Health | 20 | 2016-07-01 | 2018-01-25 | |
| Evaluation of the Efficacy of Diafert in Predicting Embryos' Potential to Develop to the Blastocyst Stage Diafert - Infertility | Completed | Forest Laboratories | 100 | 2016-06-24 | 2017-07-31 | |
| Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer CAZ-AVI, Vancomycin, Linezolid - Neoplasms, Febrile Neutropenia | Phase 2 | Terminated | Forest Laboratories | 2 | 2016-05-17 | 2017-07-21 |
| Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder Cariprazine, Placebo - Bipolar Disorder, Depression | Phase 3 | Completed | Forest Laboratories | 493 | 2016-03-31 | 2019-03-12 |
| Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression Cariprazine, Placebo - Bipolar Disorder, Depression | Phase 3 | Completed | Forest Laboratories | 488 | 2016-03-17 | 2019-01-30 |
| A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC) Placebo, LIN Dose A, LIN Dose B - Functional Constipation in Children Ages 6-17 Years | Phase 2 | Completed | Forest Laboratories | 173 | 2015-11-03 | 2019-06-19 |
| An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation Linaclotide - Irritable Bowel Syndrome With Constipation, Chronic Idiopathic Constipation | Phase 4 | Completed | Forest Laboratories | 828 | 2015-11-01 | 2019-08-22 |
| A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation Linaclotide Dose A, Linaclotide Dose B, Linaclotide Dose C - Irritable Bowel Syndrome With Constipation | Phase 2 | Terminated | Forest Laboratories | 101 | 2015-11-01 | 2020-12-28 |
| Diafert for Embryo Selection and Fertility Improvement (DESTINy) Daifert, Control Group - Infertility | Phase 3 | Completed | Forest Laboratories | 108 | 2015-10-26 | 2017-08-01 |
| Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) Linaclotide, Matching Placebo - Irritable Bowel Syndrome With Constipation | Phase 2 | Completed | Ironwood Pharmaceuticals, Inc. | 759 | 2015-10-22 | 2020-04-24 |
| Diafert® for Embryo Selection and Fertility Improvement Daifert, Control Group - Infertility | Phase 3 | Completed | Forest Laboratories | 14 | 2015-10-22 | 2017-08-01 |
| Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder Placebo, Levomilnacipran, Fluoxetine - Major Depressive Disorder | Phase 3 | Completed | Forest Laboratories | 552 | 2015-06-23 | 2020-09-07 |
| A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder Vilazodone - Major Depressive Disorder | Phase 3 | Completed | Forest Laboratories | 330 | 2015-05-02 | 2019-09-11 |
| Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22) Vilazodone, Placebo, Fluoxetine - Major Depressive Disorder | Phase 3 | Completed | Forest Laboratories | 473 | 2015-02-28 | 2019-10-01 |
| The Use of Ceftaroline as Surgical Prophylaxis in Surgery With Risk of MRSA Infection Ceftaroline, Cefazolin / Vancomycin - Surgical Site Infection | Phase 4 | Unknown | University of Cincinnati | 500 | 2015-01-01 | 2015-12-02 |
| Diafert for Embryo Selection and Fertility Improvement Daifert, Control Group - Infertility | Phase 3 | Completed | Forest Laboratories | 61 | 2014-11-25 | 2017-08-01 |
Showing 20 of 338. Sign in to see all of them.
Depression (39) · Depressive Disorder, Major (37) · Hypertension (35) · Fibromyalgia (17) · Pain (14) · Alzheimer Disease (13) · Cystic Fibrosis (12) · Exocrine Pancreatic Insufficiency (12) · Schizophrenia (12) · Bipolar Disorder (9) · Diabetes Mellitus, Type 2 (9) · Infections (8) · Anxiety Disorders (7) · Autistic Disorder (7) · Diabetes Mellitus (7)
Memantine (41) · Nebivolol (39) · Escitalopram (35) · Milnacipran (28) · Ceftaroline (26) · cariprazine (20) · Metoprolol (18) · Vilazodone Hydrochloride (18) · linaclotide (12) · Sugars (10) · Levomilnacipran (9) · Vancomycin (9) · Acamprosate (8) · dutogliptin (8) · azimilide (7)
United States (302) · Poland (30) · Ukraine (30) · Canada (27) · Romania (23) · Germany (22) · Spain (22) · Russia (21) · Argentina (19) · Bulgaria (17) · India (17) · France (14) · Hungary (14) · Belgium (12) · Italy (11)
Carl Gommoll, MS (8) · Paul Newell, MBBS, MRCP (5) · David B Bharucha, MD, PhD, FACC (4) · Giovanna Forero, MA (4) · Willie Earley, MD (4) · Allan Spera (3) · Ashwin A Patkar, MD (3) · Elizabeth Diaz, MD (3) · Eric Sicard, M.D. (3) · Jeffrey M. Johnston, MD, FACP (3) · Jordan Lateiner, MS, MBA (3) · Jose M Brum, MD (3) · Kaity Posada, PharmD (3)
PMID 33854317, PMID 34091867, PMID 30597021, PMID 34922058, PMID 30221827, PMID 26644957, PMID 29912399, PMID 30061279, PMID 31969269, PMID 32602065, PMID 36006807, PMID 26702925, PMID 27486544, PMID 28692485, PMID 29017067, PMID 29608461, PMID 30380060, PMID 30470662, PMID 30716446, PMID 31344528, PMID 32942346, PMID 33677183, PMID 33915374, PMID 34741280, PMID 37700689, PMID 39520655, PMID 20695801, PMID 21115456, PMID 21438794, PMID 21482570, PMID 21830967, PMID 22106941, PMID 23116208, PMID 23216998, PMID 23357290, PMID 24075889, PMID 24127687, PMID 25312449, PMID 25487791, PMID 26112278, PMID 26845266, PMID 27313268, PMID 27585969, PMID 28478771, PMID 28836957, PMID 31044546, PMID 37551609, PMID 37811711, PMID 39989849, PMID 10109801
2016 (2), 1KL2RR025015-01 (1), 1RL1AG032115-01 (1), 2009 (1), 2014 (1), K23AR057578 (1), P50DA012756 (1), R01MH059380 (1), R01MH059381 (1), R01MH065653 (1), R01MH079414 (1)